Go Pro

Contineum Therapeutics (CTNM) News Today

Contineum Therapeutics logo
$14.82 +0.16 (+1.09%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$14.81 -0.01 (-0.07%)
As of 09/11/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Contineum Therapeutics Latest News

Contineum Therapeutics (NASDAQ:CTNM) Shares Gap Down - Here's Why
Contineum Therapeutics Stock Price History
Contineum Therapeutics Inc trading resumes

Contineum Therapeutics Media Mentions By Week

Contineum Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CTNM
News Sentiment

1.16

0.88

Average
Healthcare
News Sentiment

Contineum Therapeutics News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CTNM Articles
This Week

4

2

CTNM Articles
Average Week

Contineum Therapeutics Trends on MarketBeat

This week vs. last week
New Followers
1
Page Views
2,013
+13%
Get Contineum Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CTNM and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Contineum Therapeutics dated 9/11/2026.
From Our Partners